Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with 161Tb and 177Lu: A Comparative Study.
Holzleitner N, Cwojdzinski T, Beck R, Urtz-Urban N, Hillhouse CC, Grundler PV, van der Meulen NP, Talip Z, Ramaekers S, Van de Voorde M, Ponsard B, Casini A, Günther T. Holzleitner N, et al. Among authors: van de voorde m. J Nucl Med. 2024 Mar 1;65(3):481-484. doi: 10.2967/jnumed.123.266233. J Nucl Med. 2024. PMID: 38124121 Free PMC article.
Predicting yield of individual field-grown rapeseed plants from rosette-stage leaf gene expression.
De Meyer S, Cruz DF, De Swaef T, Lootens P, De Block J, Bird K, Sprenger H, Van de Voorde M, Hawinkel S, Van Hautegem T, Inzé D, Nelissen H, Roldán-Ruiz I, Maere S. De Meyer S, et al. Among authors: van de voorde m. PLoS Comput Biol. 2023 May 30;19(5):e1011161. doi: 10.1371/journal.pcbi.1011161. eCollection 2023 May. PLoS Comput Biol. 2023. PMID: 37253069 Free PMC article.
Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE-A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours.
Wharton L, McNeil SW, Merkens H, Yuan Z, Van de Voorde M, Engudar G, Ingham A, Koniar H, Rodríguez-Rodríguez C, Radchenko V, Ooms M, Kunz P, Bénard F, Schaffer P, Yang H. Wharton L, et al. Among authors: van de voorde m. Molecules. 2023 Apr 1;28(7):3155. doi: 10.3390/molecules28073155. Molecules. 2023. PMID: 37049918 Free PMC article.
Comparative Study of a Decadentate Acyclic Chelate, HOPO-O10, and Its Octadentate Analogue, HOPO-O8, for Radiopharmaceutical Applications.
Carbo-Bague I, Li C, McNeil BL, Gao Y, McDonagh AW, Van de Voorde M, Ooms M, Kunz P, Yang H, Radchenko V, Schreckenbach G, Ramogida CF. Carbo-Bague I, et al. Among authors: van de voorde m. Inorg Chem. 2023 Dec 18;62(50):20549-20566. doi: 10.1021/acs.inorgchem.2c03671. Epub 2023 Jan 6. Inorg Chem. 2023. PMID: 36608341
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE.
Vermeulen K, Van de Voorde M, Segers C, Coolkens A, Rodriguez Pérez S, Daems N, Duchemin C, Crabbé M, Opsomer T, Saldarriaga Vargas C, Heinke R, Lambert L, Bernerd C, Burgoyne AR, Cocolios TE, Stora T, Ooms M. Vermeulen K, et al. Among authors: van de voorde m. Pharmaceutics. 2022 Nov 23;14(12):2566. doi: 10.3390/pharmaceutics14122566. Pharmaceutics. 2022. PMID: 36559060 Free PMC article.
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy.
Van de Voorde M, Duchemin C, Heinke R, Lambert L, Chevallay E, Schneider T, Van Stenis M, Cocolios TE, Cardinaels T, Ponsard B, Ooms M, Stora T, Burgoyne AR. Van de Voorde M, et al. Front Med (Lausanne). 2021 Jul 19;8:675221. doi: 10.3389/fmed.2021.675221. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34350194 Free PMC article.
12 results